Researchers at UCL’s Cancer Institute are making significant strides in understanding how cell signaling pathways contribute to cancer development and progression. Their work focuses on how signals within cells control growth, survival, and response to treatments, with the goal of identifying new therapeutic targets. By studying these intricate communication networks, scientists can uncover vulnerabilities in cancer cells that could lead to more effective treatments.
A key aspect of this research is the development of drugs that can selectively disrupt harmful signaling pathways without affecting normal cells. This precision approach aims to improve treatment efficacy while minimizing side effects. The findings from UCL’s cell signaling oncology research have the potential to revolutionize cancer therapy by offering more tailored and targeted interventions for patients. Click for More Details
